Published in J Pediatr Gastroenterol Nutr on November 01, 2002
Endoscopic retrograde cholangiopancreatography in pancreatic and biliary tract disease in Korean children. World J Gastroenterol (2010) 0.89
Role of magnetic resonance cholangiopancreatography in diagnosing choledochal cysts: Case series and review. World J Radiol (2013) 0.89
Pancreatitis and the role of US, MRCP and ERCP. Pediatr Radiol (2009) 0.82
Wire-guided cannulation versus contrast-guided cannulation in pediatric endoscopic retrograde cholangiopancreatography. Saudi J Gastroenterol (2015) 0.80
Pediatric ERCP in a multidisciplinary community setting: experience with a fellowship-trained general surgeon. Surg Endosc (2007) 0.78
Comparison of performance and safety of endoscopic retrograde cholangiopancreatography across pediatric age groups. Dig Dis Sci (2013) 0.76
Acute biliary pancreatitis and cholecystolithiasis in a child: one time treatment with laparoendoscopic "rendez-vous" procedure. World J Gastroenterol (2006) 0.75
The safety and efficacy of ERCP in the pediatric population with standard scopes: Does size really matter? Springerplus (2016) 0.75
Complications of Endoscopic Retrograde Cholangiopancreatography in Pediatric Patients; A Systematic Literature Review and Meta-Analysis. J Pediatr (2016) 0.75
Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91
Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA (2004) 6.98
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med (2012) 4.51
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44
Prediction of outcome in acute lower-gastrointestinal haemorrhage based on an artificial neural network: internal and external validation of a predictive model. Lancet (2003) 3.26
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc (2007) 3.23
Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol (2009) 3.04
Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med (2006) 2.98
Risk factors for complications after performance of ERCP. Gastrointest Endosc (2002) 2.93
Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. Gastrointest Endosc (2005) 2.77
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc (2004) 2.43
Use and impact of early endoscopy in elderly patients with peptic ulcer hemorrhage: a population-based analysis. Gastrointest Endosc (2009) 2.24
Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis. Gastrointest Endosc (2004) 2.23
The changing landscape of practice patterns regarding unsedated endoscopy and propofol use: a national Web survey. Gastrointest Endosc (2005) 2.16
A primer on natural orifice transluminal endoscopic surgery: building a new paradigm. Surg Innov (2006) 1.93
Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc (2004) 1.86
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr (2008) 1.72
Sedation during endoscopy for patients at risk of obstructive sleep apnea. Gastrointest Endosc (2009) 1.68
Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc (2007) 1.67
EUS and survival in patients with pancreatic cancer: a population-based study. Gastrointest Endosc (2010) 1.66
EUS compared with endoscopy plus transabdominal US in the initial diagnostic evaluation of patients with upper abdominal pain. Gastrointest Endosc (2010) 1.66
Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds. Gastrointest Endosc (2007) 1.62
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies. Cancer Epidemiol Biomarkers Prev (2012) 1.57
Endoscopic ultrasonography and prognosis of esophageal cancer. Clin Gastroenterol Hepatol (2006) 1.56
EUS in localizing safe alternate access sites for natural orifice transluminal endoscopic surgery: initial experience in a porcine model. Gastrointest Endosc (2008) 1.54
Criteria for the diagnosis of dysplasia by endoscopic optical coherence tomography. Gastrointest Endosc (2003) 1.52
Computer-aided diagnosis of dysplasia in Barrett's esophagus using endoscopic optical coherence tomography. J Biomed Opt (2006) 1.48
Endoscopic research in America (revisited). Gastrointest Endosc (2003) 1.48
Quality indicators for endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (2006) 1.46
Prediction of outcome in acute lower gastrointestinal hemorrhage: role of artificial neural network. Eur J Gastroenterol Hepatol (2007) 1.46
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Gastrointest Endosc (2006) 1.42
Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol (2006) 1.42
Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology (2006) 1.41
Clinical utility of intraductal US for evaluation of choledocholithiasis. Gastrointest Endosc (2003) 1.41
Quality in endoscopy: it starts during fellowship. Gastrointest Endosc (2008) 1.40
Correlation of endoscopic optical coherence tomography with histology in the lower-GI tract. Gastrointest Endosc (2005) 1.39
Pediatric autonomic disorders. Pediatrics (2006) 1.36
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol (2006) 1.30
Prospective evaluation of 4-mm diameter endoscopes for esophagoscopy in sedated and unsedated patients. Gastrointest Endosc (2003) 1.28
Wireless capsule endoscopy: August 2002. Gastrointest Endosc (2002) 1.24
Small bowel capsule endoscopy in patients with cardiac pacemakers and implantable cardioverter defibrillators: Outcome analysis using telemetry review. World J Gastrointest Endosc (2012) 1.23
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc (2012) 1.19
Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia. Cancer (2002) 1.16
Natural orifice transluminal endoscopic surgery (NOTES) as a diagnostic tool in the intensive care unit. Surg Endosc (2007) 1.14
A segregation analysis of Barrett's esophagus and associated adenocarcinomas. Cancer Epidemiol Biomarkers Prev (2010) 1.13
Association of insulin and insulin-like growth factors with Barrett's oesophagus. Gut (2011) 1.13
Mechanical lithotripsy of pancreatic and biliary stones: complications and available treatment options collected from expert centers. Am J Gastroenterol (2007) 1.12
EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc (2002) 1.10
The argon plasma coagulator: February 2002. Gastrointest Endosc (2002) 1.08
Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am J Epidemiol (2005) 1.07
Endoscopic ultrasound-guided fine needle aspiration in the diagnosis of mediastinal masses of unknown origin. Am J Gastroenterol (2002) 1.07
Insulin resistance, central obesity, and risk of colorectal adenomas. Cancer (2011) 1.07
Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management. Gastrointest Endosc (2009) 1.07
Celiac disease for the endoscopist. Gastrointest Endosc (2002) 1.06
The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer (2012) 1.06
Quality indicators for esophagogastroduodenoscopy. Am J Gastroenterol (2006) 1.06
EUS 2008 Working Group document: evaluation of EUS-guided vascular therapy. Gastrointest Endosc (2009) 1.05
Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model. Surg Endosc (2012) 1.04
Quality indicators for esophagogastroduodenoscopy. Gastrointest Endosc (2006) 1.03
Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus. Gastrointest Endosc (2010) 1.03
Late phase TNF-alpha depression in natural orifice translumenal endoscopic surgery (NOTES) peritoneoscopy. Surgery (2007) 1.02
Endoscopically guided spectral-domain OCT with double-balloon catheters. Opt Express (2010) 1.01
An international survey of the clinical practice of EUS. Gastrointest Endosc (2004) 1.01
EUS: past, present, and the future of endoscopy. Gastrointest Endosc (2002) 1.00
Autonomic abnormalities in cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr (2007) 0.99
In vivo characterization of pancreatic and lymph node tissue by using EUS spectrum analysis: a validation study. Gastrointest Endosc (2009) 0.99